Royalty Pharma plc - SHS CLASS A (RPRX)

Historical Portfolio Holders from Q1 2019 to Q3 2024

All holders as of June 30, 2024
Q2 2024
Type / Class
Equity / SHS CLASS A
Shares, excl. options Q2 2024
316M
Holdings value Q2 2024
$8.33B
Value change Q2 2024
+$243M
Grand Portfolio weight change Q2 2024
+0%
Number of holders
371
Number of buys Q2 2024
42
Number of sells Q2 2024
-36
Average buys Q2 2024 %
+0.002%
Average sells Q2 2024 %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q3 21.1M $596M -$23.5M $28.29 84
2024 Q2 316M $8.33B +$243M $26.37 373
2024 Q1 307M $9.33B -$145M $30.37 373
2023 Q4 305M $8.56B +$178M $28.09 355
2023 Q3 292M $7.92B -$223M $27.14 311
2023 Q2 299M $9.19B +$13.6M $30.74 318
2023 Q1 298M $10.7B +$36.4M $36.03 326
2022 Q4 297M $11.7B +$71.8M $39.52 329
2022 Q3 296M $11.9B +$227M $40.18 309
2022 Q2 291M $12.2B +$916M $42.04 279
2022 Q1 269M $10.5B +$81.2M $38.96 270
2021 Q4 267M $10.7B +$161M $39.85 253
2021 Q3 264M $9.54B +$520M $36.14 226
2021 Q2 249M $10.2B +$87.6M $40.99 226
2021 Q1 246M $10.7B +$868M $43.62 206
2020 Q4 226M $11.3B +$1.96B $50.05 187
2020 Q3 155M $6.52B +$368M $42.07 130
2020 Q2 146M $7.03B +$7.03B $48.55 119
2020 Q1 15 $1K $0 $66.67 1
2019 Q4 15 $1K $0 $66.67 1
2019 Q3 15 $1K $0 $66.67 1
2019 Q2 15 $1K $0 $66.67 1
2019 Q1 15 $1K $0 $66.67 1